MHK
Mohawk Industries, Inc.
MHK offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
NKE
NIKE, Inc.
NKE has the edge over MHK overall, supported by stronger valuation and stronger modeled upside.
MHK Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Healthy |
MHK's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
MHK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.3x | $79.26 | -46% |
| Fair | 15x | $126 | -14% |
| Forward | 16x | $147 | — |
| Current | 17x | $147 | — |
| Expensive | 21x | $182 | +24% |
Historical ranges are pointers, not guarantees.
MHK's PE is in its expensive range at 17x. On analysts' estimates for next year's earnings, today's price would be 16x, in its fair range.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE has the edge over MHK in the historical PE scenario, which offers more potential upside but is not a forecast.
MHK Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Stable | |
| Stable | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect MHK's earnings, revenue and profitability to hold roughly steady.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
MHK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.11 | +6.8% |
| Q3 2026 | $8.53 | +27% |
| Q2 2026 | $7.56 | +0.4% |
| Q1 2026 | $6.68 | -13% |
| Q4 2025 | $5.93 | -27% |
| Q3 2025 | $6.73 | -24% |
| Q2 2025 | $7.53 | +$13.17 |
| Q1 2025 | $7.65 | +$14.17 |
| Q4 2024 | $8.14 | +$15.04 |
MHK has the edge over NKE on earnings, with more consistent year-over-year improvement.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE's earnings per share have fallen from their peak: $2.09 over the past year, against $3.82 in late 2021.
MHK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.8B | +1% |
| Q2 2026 | $3B | +6.8% |
| Q1 2026 | $2.7B | +8% |
| Q4 2025 | $2.7B | +2.4% |
| Q3 2025 | $2.8B | +1.4% |
| Q2 2025 | $2.8B | 0% |
| Q1 2025 | $2.5B | -5.7% |
| Q4 2024 | $2.6B | +1% |
MHK has the edge over NKE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.7% | +1.8 points |
| Q2 2026 | 8.5% | +1.8 points |
| Q1 2026 | 4.1% | +0.3 points |
| Q4 2025 | 2.5% | -2.1 points |
| Q3 2025 | 5% | -2.8 points |
| Q2 2025 | 6.7% | -0.9 points |
| Q1 2025 | 3.8% | -1.7 points |
| Q4 2024 | 4.6% | -1.8 points |
MHK's operating margin was 6.7% last quarter, up 1.8 points from the same quarter a year ago.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE's revenue fell from its 2023 peak and has held roughly level since: $11.2B last quarter, down 4.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE has the edge over MHK on profitability, with a higher operating margin.
MHK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $390.3M | +26% |
| Q2 2026 | $228.2M | +81% |
| Q1 2026 | $7.8M | +$93.2M |
| Q4 2025 | $265.2M | +12% |
| Q3 2025 | $310.3M | +52% |
| Q2 2025 | $126.1M | -11% |
| Q1 2025 | -$85.4M | -188% |
| Q4 2024 | $236.2M | +322% |
MHK has the edge over NKE on cash flow, with more consistent year-over-year improvement.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE usually generates cash, though not every quarter: the latest was −$64M, but it generated $2.1B over the past year.
MHK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.5% | -900K shares |
| 1 year | -3.7% | -2.3M shares |
| 3 years | -5.8% | -3.7M shares |
| 5 years | -13% | -8.9M shares |
| Available history | -17% | -12.3M shares |
MHK has the edge over NKE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $260.9M |
| Q2 2026 | $59.9M |
| Q1 2026 | $64.7M |
| Q4 2025 | $41.1M |
| Q3 2025 | $40.6M |
| Q2 2025 | $42.6M |
| Q1 2025 | $25.5M |
| Q4 2024 | $74.9M |
MHK spent $427M buying back its own shares over the past year, up 132% from the year before.
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has 1.5B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
MHK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.8x | Very low |
| Q2 2026 | 0.9x | Very low |
| Q1 2026 | 1.0x | Healthy |
| Q4 2025 | 1.0x | Healthy |
| Q3 2025 | 1.2x | Healthy |
| Q2 2025 | 1.3x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.2x | Healthy |
MHK's net debt is less than a year of its operating earnings (EBITDA), down from 1.2 years a year ago.
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE has the edge over MHK on leverage, with a lower net debt burden relative to earnings.
MHK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.4 | Neutral |
| Stochastic | 84.5 | Overbought |
MHK's weekly RSI is 64 (neutral) and its Stochastic is 85 (overbought).
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
MHK PE vs Consumer Cyclical Sector
| Metric | MHK | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 18x | 4.6% below |
| PE % | 69 | 47 | 22 pts above |
MHK has the edge over NKE on valuation relative to its sector.
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x.
MHK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $131.4 | 12% above |
| 20 week MA | $127.9 | 15% above |
| 50 week MA | $117.5 | 25% above |
| 100 week MA | $116.8 | 26% above |
| 200 week MA | $115.1 | 27% above |
MHK has the edge over NKE on trend strength, trading above more of its moving averages.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 52% below its 200-week average.
MHK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $134.4 | $138.7 | +3.2% |
| 2021 | $138.7 | $171.2 | +23% |
| 2022 | $171.2 | $98.0 | -43% |
| 2023 | $98.0 | $103.5 | +5.7% |
| 2024 | $103.5 | $118.8 | +15% |
| 2025 | $118.8 | $110.2 | -7.2% |
| 2026 YTD | $110.2 | $146.6 | +33% |
MHK has the edge over NKE on returns for 2026, with the stronger performance.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has finished four years in a row lower, and it's down 38% so far in 2026.